Dr. Robert A. Nagourney, MDAug 29, 20222 minIN HER2 (+) BREAST CANCER, THE MOST WIDELY USED TREATMENT MAY NOT BE THE RIGHT ONE FOR YOUDespite advances in breast cancer management, we must all recognize that every patient is unique and their treatments should be too.
Dr. Robert A. Nagourney, MDFeb 15, 20214 minIN LUNG AND BREAST CANCER COMBINED CHEMO-IMMUNOTHERAPY LOOKS BEST, BUT WHICH DRUGS?With the explosion of immunotherapy in oncology, the checkpoint inhibitors (Pembrolizumab, Nivolumab, Ipililumab, etc.) are being used in...